Sexual dysfunction in female cancer survivors: Addressing the problems and the remedies

被引:10
|
作者
Smith, Taryn [1 ,2 ,4 ]
Kingsberg, Sheryl A. [3 ]
Faubion, Stephanie [1 ,2 ]
机构
[1] Div Gen Internal Med, Mayo Clin, Jacksonville, FL USA
[2] Mayo Clin Womens Hlth, Rochester, MN USA
[3] Univ Hosp Cleveland Med Ctr, Dept OBGYN, Cleveland, OH USA
[4] Div Gen Internal Med, Mayo Clin, Sect Womens Hlth, 4500 San Pablo Rd S-Davis 8, Jacksonville, FL 32224 USA
关键词
Female sexual dysfunction; cancer survivorship; Menopause; Female sexual health; QUALITY-OF-LIFE; BREAST-CANCER; POSTMENOPAUSAL WOMEN; CERVICAL-CANCER; HEALTH ISSUES; INDEX FSFI; VALIDATION; INTERVENTION; ADJUSTMENT; DIFFERENCE;
D O I
10.1016/j.maturitas.2022.07.010
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
This narrative review examines current evidence regarding sexual function in female cancer survivors, focusing on the impact of cancer treatments as well as the evaluation and management of sexual concerns in this population. Sexual dysfunction in female cancer survivors is prevalent, yet underdiagnosed and undertreated. Many healthcare professionals feel ill-equipped to address the sexual health needs of female cancer survivors. Multiple direct and indirect factors can contribute to sexual dysfunction in female cancer survivors, including effects on the hormonal milieu and physical and sexual well-being. Factors influencing sexual function after cancer may be multifaceted, warranting a multidisciplinary approach to care. Validating and normalizing sexual health concerns and providing education and appropriate therapies, as well as timely referral to appropriate sexual health experts, are key to optimizing cancer survivorship care in women. Clinicians should, at a minimum, be aware of the various potential treatment modalities, taking into account contributing physical, psychological and interpersonal factors. Management of sexual health concerns should be individualized based on contributing factors.
引用
收藏
页码:52 / 57
页数:6
相关论文
共 50 条
  • [31] Sexual Dysfunction and Aromatase Inhibitor Use in Survivors of Breast Cancer
    Kwan, Karen W.
    Chlebowski, Rowan T.
    CLINICAL BREAST CANCER, 2009, 9 (04) : 219 - 224
  • [32] Fertility and sexual function in female Hodgkin lymphoma survivors of reproductive age
    Eeltink, Corien M.
    Incrocci, Luca
    Witte, Birgit I.
    Meurs, Saskia
    Visser, Otto
    Huijgens, Peter
    Verdonck-de Leeuw, Irma M.
    JOURNAL OF CLINICAL NURSING, 2013, 22 (23-24) : 3513 - 3521
  • [33] Sexual functioning of cervical cancer survivors: A review with a female perspective
    Lammerink, Ellen A. G.
    de Bock, Geertruida H.
    Pras, Elisabeth
    Reyners, Anna K. L.
    Mourits, Marian J. E.
    MATURITAS, 2012, 72 (04) : 296 - 304
  • [34] Female sexual dysfunction in postmenopausal women
    Castelo-Branco, Camil
    Cancelo, Maria J.
    Chedraui, Peter
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2007, 17 (06) : 639 - 647
  • [35] Female Sexual Dysfunction
    Clayton, Anita H.
    Hamilton, David V.
    PSYCHIATRIC CLINICS OF NORTH AMERICA, 2010, 33 (02) : 323 - +
  • [36] Female Sexual Dysfunction
    Clayton, Anita H.
    Juarez, Elia Margarita Valladares
    MEDICAL CLINICS OF NORTH AMERICA, 2019, 103 (04) : 681 - +
  • [37] Medical Treatment of Female Sexual Dysfunction
    Nappi, Rossella E.
    Tiranini, Lara
    Martini, Ellis
    Bosoni, David
    Righi, Alessandra
    Cucinella, Laura
    UROLOGIC CLINICS OF NORTH AMERICA, 2022, 49 (02) : 299 - 307
  • [38] Female Sexual Dysfunction
    Clayton, Anita H.
    Juarez, Elia Margarita Valladares
    PSYCHIATRIC CLINICS OF NORTH AMERICA, 2017, 40 (02) : 267 - +
  • [39] Female Sexual Dysfunction
    Clayton, Anita H.
    Hamilton, David V.
    OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA, 2009, 36 (04) : 861 - +
  • [40] Prevalence of pelvic floor dysfunction and sexual dysfunction in cervical cancer survivors: a systematic review and meta-analysis
    Shan, Xiao
    Qian, Maolin
    Wang, Lan
    Liu, Xiaoqin
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2023, 34 (03) : 655 - 664